Cargando…
Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2
The COVID-19 pandemic accelerated the development of decentralized clinical trials (DCT). DCT’s are an important and pragmatic method for assessing health outcomes yet comprise only a minority of clinical trials, and few published methodologies exist. In this report, we detail the operational compon...
Autores principales: | Avula, Nandini, Kakach, Dustin, Tignanelli, Christopher J., Liebovitz, David M., Nicklas, Jacinda M., Cohen, Kenneth, Puskarich, Michael A., Belani, Hrishikesh K., Buse, John B., Klatt, Nichole R., Anderson, Blake, Karger, Amy B., Hartman, Katrina M., Patel, Barkha, Fenno, Sarah L., Reddy, Neha V., Erickson, Spencer M., Boulware, David R., Murray, Thomas A., Bramante, Carolyn T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685265/ https://www.ncbi.nlm.nih.gov/pubmed/38033705 http://dx.doi.org/10.1017/cts.2023.668 |
Ejemplares similares
-
68 Metformin prevents the diagnosis of Long Covid in phase 3 trial of early treatment.
por: Bramante, Carolyn, et al.
Publicado: (2023) -
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up
por: Bramante, Carolyn T., et al.
Publicado: (2022) -
Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic Symptoms
por: Bramante, Carolyn T, et al.
Publicado: (2022) -
Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial
por: Bramante, Carolyn T, et al.
Publicado: (2023) -
Outpatient metformin use is associated with reduced severity of COVID‐19 disease in adults with overweight or obesity
por: Bramante, Carolyn T., et al.
Publicado: (2021)